Screener
Galectin Therapeutics GALT Q1 2026 Annual earnings
Reported May 15, 2026 · Before market open
EPS-$0.08Miss by $0.02
EPS estimate-$0.06
Next report
Nov 13, 2026 (in 2 months)EPS estimate-$0.05
Versus estimates
Diluted EPS
FAQ
- When did Galectin Therapeutics report Q1 2026 earnings?
- Galectin Therapeutics (GALT) reported Q1 2026 earnings on May 15, 2026 before market open.
- What were Galectin Therapeutics's Q1 2026 revenue and EPS?
- Galectin Therapeutics reported eps of $-0.08 for Q1 2026.
- Did Galectin Therapeutics beat estimates in Q1 2026?
- EPS missed the consensus estimate of $-0.06 by $0.02.
- How did Galectin Therapeutics's Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 46.7% from $-0.15.
- Where can I find Galectin Therapeutics's Q1 2026 SEC filings?
- You can read the 8-K earnings release (0001140361-26-021496) and the 10-K periodic report (0001140361-26-012155) directly on SEC EDGAR. The filing index links above go to sec.gov.
